ADAP – Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plcADAP
$0.5799Name : Adaptimmune Therapeutics plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $148,386,560.00
EPSttm : -0.17
Adaptimmune Therapeutics plc
$0.5799
1.71%$0.0101Float Short %
2.43
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
0.07
EPS Last/This Y
0.4
EPS This/Next Y
-0.33
Price
0.58
Target Price
2.71
Analyst Recom
1.89
Performance Q
-33.42
Relative Volume
0.28
Beta
2.41
Ticker: ADAP
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | ADAP | 0.5947 | 0.05 | 0.00 | 4125 |
| 2024-12-20 | ADAP | 0.5997 | 0.05 | 0.00 | 4121 |
| 2024-12-23 | ADAP | 0.59 | 0.05 | 0.00 | 2950 |
| 2024-12-24 | ADAP | 0.58 | 0.05 | 0.68 | 3035 |
| 2024-12-26 | ADAP | 0.5691 | 0.04 | 0.03 | 3022 |
| 2024-12-27 | ADAP | 0.5856 | 0.04 | 0.00 | 3039 |
| 2024-12-30 | ADAP | 0.5563 | 0.04 | 2.73 | 3040 |
| 2024-12-31 | ADAP | 0.537 | 0.07 | 0.09 | 3155 |
| 2025-01-02 | ADAP | 0.6306 | 0.07 | 0.00 | 3167 |
| 2025-01-03 | ADAP | 0.6474 | 0.07 | 0.00 | 3208 |
| 2025-01-06 | ADAP | 0.6492 | 0.07 | 0.04 | 3224 |
| 2025-01-07 | ADAP | 0.6545 | 0.07 | 0.00 | 3238 |
| 2025-01-08 | ADAP | 0.6258 | 0.07 | 0.00 | 3243 |
| 2025-01-09 | ADAP | 0.6199 | 0.07 | 0.00 | 3243 |
| 2025-01-10 | ADAP | 0.6196 | 0.07 | 0.00 | 3268 |
| 2025-01-13 | ADAP | 0.5935 | 0.07 | 1.00 | 3267 |
| 2025-01-14 | ADAP | 0.5838 | 0.07 | 0.10 | 3258 |
| 2025-01-15 | ADAP | 0.6102 | 0.07 | 999.99 | 3279 |
| 2025-01-16 | ADAP | 0.5896 | 0.07 | 2.50 | 3279 |
| 2025-01-17 | ADAP | 0.58 | 0.08 | 0.00 | 3349 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | ADAP | 0.60 | 35.8 | - | -0.14 |
| 2024-12-20 | ADAP | 0.60 | 35.8 | - | -0.14 |
| 2024-12-23 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2024-12-24 | ADAP | 0.58 | 35.8 | - | -0.14 |
| 2024-12-26 | ADAP | 0.57 | 35.8 | - | -0.14 |
| 2024-12-27 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2024-12-30 | ADAP | 0.56 | 35.8 | - | -0.14 |
| 2024-12-31 | ADAP | 0.54 | 35.8 | - | -0.14 |
| 2025-01-02 | ADAP | 0.62 | 35.8 | - | -0.14 |
| 2025-01-03 | ADAP | 0.65 | 35.8 | - | -0.14 |
| 2025-01-06 | ADAP | 0.65 | 35.8 | - | -0.14 |
| 2025-01-07 | ADAP | 0.66 | 35.8 | - | -0.14 |
| 2025-01-08 | ADAP | 0.62 | 35.8 | - | -0.14 |
| 2025-01-09 | ADAP | 0.62 | 35.8 | - | -0.14 |
| 2025-01-10 | ADAP | 0.62 | 35.8 | - | -0.14 |
| 2025-01-13 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-01-14 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-01-15 | ADAP | 0.61 | 35.8 | - | -0.14 |
| 2025-01-16 | ADAP | 0.59 | 35.8 | - | -0.14 |
| 2025-01-17 | ADAP | 0.58 | 35.8 | - | -0.14 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | ADAP | 0.00 | -22.02 | 2.97 |
| 2024-12-20 | ADAP | 0.00 | -22.02 | 2.97 |
| 2024-12-23 | ADAP | 0.00 | -21.83 | 2.97 |
| 2024-12-24 | ADAP | 0.00 | -21.83 | 2.97 |
| 2024-12-26 | ADAP | 0.00 | -21.83 | 2.24 |
| 2024-12-27 | ADAP | 0.00 | -21.83 | 2.24 |
| 2024-12-30 | ADAP | 0.00 | -22.50 | 2.24 |
| 2024-12-31 | ADAP | 0.00 | -22.50 | 2.24 |
| 2025-01-02 | ADAP | 0.00 | -22.50 | 2.24 |
| 2025-01-03 | ADAP | 0.00 | -22.50 | 2.24 |
| 2025-01-06 | ADAP | 0.00 | -21.83 | 2.24 |
| 2025-01-07 | ADAP | 0.00 | -21.83 | 2.24 |
| 2025-01-08 | ADAP | 0.00 | -21.83 | 2.24 |
| 2025-01-09 | ADAP | 0.00 | -21.83 | 2.24 |
| 2025-01-10 | ADAP | 0.00 | -21.83 | 2.24 |
| 2025-01-13 | ADAP | 0.00 | -21.83 | 2.43 |
| 2025-01-14 | ADAP | 0.00 | -21.83 | 2.43 |
| 2025-01-15 | ADAP | -0.45 | -21.83 | 2.43 |
| 2025-01-16 | ADAP | -0.45 | -21.83 | 2.43 |
| 2025-01-17 | ADAP | -0.45 | -21.83 | 2.43 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
Insider Transactions
-0.45
Institutional Transactions
-21.83
Beta
2.41
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
15
Growth Score
40
Sentiment Score
30
Actual DrawDown %
95.7
Max Drawdown 5-Year %
-96.5
Target Price
2.71
P/E
Forward P/E
PEG
P/S
0.85
P/B
1.85
P/Free Cash Flow
EPS
-0.21
Average EPS Est. Cur. Y
-0.14
EPS Next Y. (Est.)
-0.47
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-25.63
Relative Volume
0.28
Return on Equity vs Sector %
-74.7
Return on Equity vs Industry %
-62.1
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.15
EBIT Estimation
Adaptimmune Therapeutics plcSector: Healthcare
Industry: Biotechnology
Employees: 449
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
stock quote shares ADAP – Adaptimmune Therapeutics plc Stock Price stock today
news today ADAP – Adaptimmune Therapeutics plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADAP – Adaptimmune Therapeutics plc yahoo finance google finance
stock history ADAP – Adaptimmune Therapeutics plc invest stock market
stock prices ADAP premarket after hours
ticker ADAP fair value insiders trading